Ex Parte BLACKBURN et al - Page 4


                Appeal No.  2003-0480                                                   Page 4                
                Application No.  08/090245                                                                    
                Claim 87 will stand or fall together with claim 86.  Claims 89 and 90 will stand or           
                fall together with claim 88.  37 CFR § 1.192(c)(7).                                           
                                                DISCUSSION                                                    
                      “The test for obviousness is not express suggestion of the claimed                      
                invention in any or all of the references but rather what the references taken                
                collectively would suggest to those of ordinary skill in the art presumed to be               
                familiar with them.”  In re Rosselet, 347 F.2d 847, 851, 146 USPQ 183,                        
                186 (CCPA 1965).                                                                              
                      According to the examiner (Answer, page 4), Schochetman discloses “a                    
                method for the preparation and use of [catalytic] monoclonal antibodies as                    
                convenient, readily obtainable and inexpensive catalysts having a degree of                   
                specificity and efficiency of action not previously achievable in the catalytic               
                arts….”  While Schochetman does not disclose a catalytic antibody immobilized                 
                on a surface of, or on a surface associated with, a sensing means, the examiner               
                emphasizes (Answer, page 5), Schochetman discloses “[i]n addition to solution                 
                phase and emulsion reaction systems, suitable conditions also include the use of              
                support materials to which the monoclonal antibody is attached.  Such support                 
                materials are well-known to those of ordinary skill in the art as are methods for             
                attaching monoclonal antibodies to them….”                                                    
                      The examiner relies on Schenck and Conover (id.), as “representative of                 
                the state of the art of enzyme sensors and antibody sensors at the time of the                
                invention.”  According to the examiner (Answer, bridging paragraph, pages 5-6),               
                      Schenck discloses a field effect transistor which senses and                            
                      measures the binding of a substrate to an antibody which is                             






Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007